Co-Chairs: Frank Vandendriessche and Paula van Hennik
The Benelux IN group supports TOPRA members who live and work in Belgium, the Netherlands and Luxembourg or have an interest in healthcare regulatory affairs topics relevant to the Benelux. The group was relaunched in 2024, and its vision, mission, objectives and governance principles were agreed in early 2025, which are aligned to those of TOPRA.
Activities going forward will be enhanced in the following ways:
The steering group embers will work on, lead and be present at webinars which are accessible to all TOPRA members (non-member access is subject to a modest charge) and webinars are also available on-demand post-broadcast.
There will also be more frequent informal sessions accessible to TOPRA members to encourage networking opportunities.
Topics that will be covered in 2025 include:
The Belgian Federal Agency for Medicines and Health Products (FAHMP/FAGG/AFMPS)
The Dutch Medicines Evaluation Board/College ter Beoordeling van Geneesmiddelen (MEB/CBG)
The Health Technology Assessment (HTA) Regulation and how it can impact at local company affiliate level
The impact of the Clinical Trials Regulation (CTR)
A Chemistry, Manufacturing and Controls (CMC) topic – tbc
Interested in joining the Benelux IN Steering Group? Please contact gloria.dwyer@topra.org to get involved.
Chair: Ekaterina Borcheva-Dancheva
Co-Chair: Alenka Dražumerič
The Central Eastern European (CEE) IN group supports TOPRA members who live and work in Bulgaria, Croatia, Czechia, Latvia, Romania and Slovenia
as well as those with an interest in healthcare regulatory affairs topics relevant to these regions.
Our current group discussions include:
•
Country representation of TOPRA members across CEE
•
Drug/Biologics/MDD Pre-marketing and post-marketing regulatory challenges.
•
Specific focus on EU Clinical trial and MDD Regulations, CMC, labelling, regulatory frame in CIS countries (and the impact of the ongoing Russo-Ukrainian conflict)
•
Webinars held in EU drug and device regulation changes and in country implementations; herbal medicines; labelling for registered drugs; regulatory rules and updates within the CIS region and non-EU Balkan countries.
We also have upcoming webinars planned for October and November 2025 on Western Balkan markets and challenges in EU regulatory projects involving combined drug-device studies.
We're excited to extend participation from regulatory professionals from Albania, Greece, Hungary, Montenegro, North Macedonia, Poland, Serbia and Slovakia.
Interested in joining the CEE IN Steering Group? Please contact
gloria.dwyer@topra.org to get involved.
Chair: Dr Christian Monnerjahn FTOPRA
Co-Chair: Dr Inka Gallitz
TOPRA IN DACH was launched in October 2024 to expand the former TOPRA IN Germany group to a wider IN community dedicated to networking and knowledge sharing for TOPRA members who live and work in Germany, Austria and Switzerland.
The group’s vision is to support members’ professional development by offering and encouraging participation in activities including:
•
Networking – on a virtual, hybrid and in-person basis; with the possibility of regional “Stammtisch” meetings in the future and informal gatherings
•
In-depth discussion of current hot topics in regulatory affairs in formats accessible to the whole TOPRA community such as webinars, CPD training courses or publications in TOPRA’s Regulatory Rapporteur and podcasts
•
Collaborations with other TOPRA SPIN and IN groups
Topics that will be covered in 2025 include:
• A visible presence of the group at the TOPRA Symposium in Berlin (29 September – 1 October 2025) with a general presentation of the group and offering a event open to all interested members elaborating a specific (to be selected) topic in the wide AI area for presentation in an established TOPRA format, e.g. as webinar
• Evaluating the potential of collaborating with regional regulatory agencies (BfArM, Swiss Medic, BSAG, AGES) and organisations specific to regulatory affairs professionals (DGRA, MEGRA)
• Establishing a forum for easy access conversations and question on current topics of interests at one-to-one group meetings.
If you are interested in joining our dynamic group, please contact
gloria.dwyer@topra.org – and make sure you meet us at the
Symposium in Berlin!
Join the conversation
This IN group supports TOPRA members who are living and working in France.
Join the conversation
Chair: Abhishek Sinha
Co-Chair: Anoop Mishra
After five years, TOPRA IN India continues to represent the Indian regulatory affairs community globally. Our mission remains focused on enhancing awareness of the fast-evolving Indian regulatory framework and fostering meaningful international engagement.
The Indian pharmaceutical industry is a major global player, ranking third in volume and fourteenth in value as per data from the Department of Pharmaceuticals published in 2024. The Indian generics industry holds approximately 20% of global market share by volume.
In this context, TOPRA IN India provides a collaborative platform for emerging and established regulatory professionals to exchange ideas and information with the wider TOPRA community.
Our activities over the past years have included:
- Webinars addressing key regulatory topics
- Joint initiatives with TOPRA SPINs for information sharing
- Contributions to TOPRA’s Regulatory Rapporteur through insightful articles
- Successful in-person events – one held with Association of Regulatory Affairs Professionals (ARAP) and a recent collaboration with Informa in Mumbai.
As we move forward, the aim is to further strengthen ties with our global partners and continue shaping conversations on regulatory evolution.
Interested in joining the TOPRA IN India Steering Group? Please contact gloria.dwyer@topra.org to get involved.
Chair: Brian Cleary
Co-Chair: TBC
TOPRA IN Ireland was established to build a dedicated community for regulatory professionals who live and work across the country. Evolving from previous member initiatives, this group is part of
TOPRA’s wider IN network, aimed at fostering connection, learning and professional development.
The vision of TOPRA in Ireland is to empower regulatory affairs professionals by creating opportunities for:
Networking and community engagement – Throughout each year, there are numerous opportunities for members to participate in events, network with colleagues in industry and learn from others. We have a regular schedule of events, and we recently hosted an evening meeting at the HPRA with a variety of speakers looking at the impact of artificial intelligence on the regulatory function. We also run site tours of world class pharmaceutical and medical device plants, and networking events for members.
Regulatory knowledge exchange – Facilitating discussion on emerging topics in regulatory science and policy relevant to Ireland and the broader EU landscape, using accessible formats.
Cross-group collaboration – Working with other TOPRA “IN” and “SPIN” groups to promote knowledge sharing, inclusivity and interdisciplinary dialogue across regulatory functions.
Whether you are working in industry, consultancy, academia or within regulatory authorities, TOPRA in Ireland is an ideal platform to connect, contribute and grow.
Interested in joining the TOPRA IN Ireland Steering Group? Please contact gloria.dwyer@topra.org to get involved.
This IN group supports TOPRA members who are living and working in Scotland.
Join the conversation
This IN group supports TOPRA members who are living and working in Sweden.
Join the conversation